DIFLUNISAL
Drug timelines are a Plus or Pro feature.
15 regulatory and trial events tracked for DIFLUNISAL, covering 2006-12-14 to 2024-11-21. Get the full timeline:
Most recent: FDA Approved: DIFLUNISAL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)